Ethiopia's Growing Malaria Drug Resistance Posing Threat to Frontline Treatment, New Study Reveals

[Addis Standard] Addis Abeba -- A nationwide genomic surveillance study has identified widespread antimalarial drug-resistance markers in Ethiopia, including mutations associated with partial artemisinin resistance, raising concerns over the continued effectiveness of artemether-lumefantrine, the country's first-line treatment for Plasmodium falciparum malaria.